What is the differential diagnosis for pruritic, extremity‑limited spongiotic dermatitis in a 51‑year‑old woman with Crohn’s disease and a carcinoid tumor who is not taking ustekinumab (Stelara) or hydroxychloroquine and has no celiac disease?

Differential Diagnosis of Pruritic Extremity-Limited Spongiotic Dermatitis in Crohn's Disease with Carcinoid Tumor

The most likely diagnosis in this patient is allergic or irritant contact dermatitis, followed by atopic dermatitis/eczema, with bowel-associated dermatosis-arthritis syndrome being a less common but important IBD-specific consideration.

Primary Differential Considerations

Contact Dermatitis (Most Likely)

Contact dermatitis—both allergic and irritant types—is the most common cause of spongiotic dermatitis with pruritus limited to the extremities. 1 The extremity-only distribution is highly characteristic of contact exposure patterns.

• Allergic contact dermatitis occurs in susceptible individuals exposed to metals (nickel, silver), chemicals (cosmetics, soaps, detergents), plastics, rubber, or topical medications 1
• Irritant contact dermatitis results from repetitive exposure to detergents, soaps, or other irritants causing direct chemical damage 1
• The histologic finding of spongiosis with inflammatory changes is consistent with both types 1
• Key diagnostic step: Patch testing should be offered for chronic or persistent dermatitis, as clinical features alone cannot reliably distinguish allergic from irritant contact dermatitis 1

Atopic Dermatitis/Eczema

Eczema presents with chronic pruritus and demonstrates spongiotic changes histologically, with features including erythema, xerotic scaling, and lichenification depending on the stage 1. While typically starting in childhood, adult-onset eczema can occur 1. The extremity distribution can be seen in atopic dermatitis, though it more commonly involves multiple body areas 1.

IBD-Associated Dermatoses

Bowel-associated dermatosis-arthritis syndrome is a rare but specific manifestation of Crohn's disease that warrants consideration 1:

• Characterized by arthralgia, polyarthritis, and vesiculopustular eruptions typically on upper limbs and trunk 1
• Skin lesions develop over 24-48 hours and usually resolve spontaneously within 8 days 1
• Biopsy classically shows perivascular and diffuse neutrophilic infiltrate without leucocytoclastic vasculitis 1
• However, the histology described (spongiotic with inflammatory changes) does not match the typical neutrophilic infiltrate pattern, making this diagnosis less likely 1

Other IBD-related skin manifestations to consider include:

• Erythema nodosum: Presents as tender subcutaneous nodules on anterior tibial areas, not as pruritic spongiotic dermatitis 1
• Pyoderma gangrenosum: Begins as pustules becoming deep ulcerations with violaceous edges, not spongiotic dermatitis 1
• Sweet's syndrome: Tender red nodules/papules on upper limbs, face, or neck with neutrophilic infiltrate 1

Medication-Related Considerations

Paradoxical Anti-TNF Reactions

While the patient is reportedly not on Stelara (ustekinumab), if there is any history of anti-TNF therapy:

• Anti-TNF agents can induce paradoxical skin inflammation, which is a class-drug effect and usually reversible 1
• This typically presents as psoriasiform or eczematous eruptions 1

Drug Hypersensitivity

Spongiotic dermatitis with eosinophils can represent drug-induced hypersensitivity reactions 2, 3. A thorough medication history is essential, including:

• Recent medication changes
• Over-the-counter products
• Topical preparations

Carcinoid-Related Dermatologic Manifestations

Carcinoid tumors rarely cause pruritic spongiotic dermatitis. Carcinoid syndrome typically presents with flushing, diarrhea, and bronchospasm rather than chronic pruritic dermatitis 1. However, paraneoplastic pruritus should be considered if systemic symptoms develop 1.

Diagnostic Approach

Essential Investigations

1. Detailed exposure history: Occupational exposures, new products (soaps, detergents, cosmetics, jewelry, clothing), hobbies 1
2. Patch testing: Should be offered for chronic/persistent dermatitis to identify specific allergens 1
3. Review skin biopsy: Confirm spongiotic pattern and characterize inflammatory infiltrate (eosinophils vs. neutrophils) 1, 2

Additional Considerations

• Rule out superimposed infection: Bacterial or fungal cultures if secondary infection suspected 1
• Assess IBD activity: Correlation with Crohn's disease flares, though the spongiotic pattern makes bowel-associated dermatosis less likely 1
• Medication review: Complete list including recent additions or changes 3

Common Pitfalls

• Mistaking contact dermatitis for cellulitis: Bilateral extremity involvement with erythema can be misdiagnosed as infection 4
• Assuming all rashes in IBD patients are IBD-related: Contact dermatitis and atopic dermatitis are far more common than IBD-specific dermatoses 1
• Overlooking occupational exposures: Detailed work history is essential for identifying irritant or allergic triggers 1
• Failing to perform patch testing: This is the definitive diagnostic test for allergic contact dermatitis and should not be deferred indefinitely 1

Management Implications

Initial management should focus on identifying and eliminating potential contactants while providing symptomatic relief with topical corticosteroids and emollients 1. If patch testing identifies specific allergens, strict avoidance is curative 1. For refractory cases where contact dermatitis is excluded, consider topical tacrolimus or systemic immunosuppression 1.